Skip to content

Addiction: all studies

Page 681 of 860: studies 6,801 to 6,810 of 8,594, newest first. Back to the addiction overview

Research

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

Drug Testing and Analysis 2014 Claudio Vidal Giné, Iván Fornís Espinosa, Mireia Ventura Vilamala 135 citations

The use of new psychoactive substances (NPS) as adulterants has received little attention in the literature. In this paper, results from Energy Control's drug checking service documenting the use of NPS as adulterants of controlled drugs are presented, and some reflections about possible explanations for this new phenomenon, potential risks for users, and challenges that it poses are discussed....

DOI: 10.1002/dta.1610 (opens in new tab) Full text (opens in new tab) Controlled drugs Illegal market New psychoactive substances Compounds +4

New phenethylamines in Europe.

Drug Testing and Analysis 2014 L A King 81 citations

Sixteen phenethylamines are now included in Schedules I and II of the United Nations 1971 Convention on Psychotropic Substances. Most of the ring-substituted compounds are in Schedule I, whereas 2C-B, amphetamine, and methamphetamine are listed in Schedule II. Substances in Schedule IV (e.g. benzphetamine) are now regarded as obsolete pharmaceutical products. They all represent the 'old...

DOI: 10.1002/dta.1570 (opens in new tab) Full text (opens in new tab) Emcdda Amphetamine derivatives Novel recreational drugs Illicit phenethylamines +15

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Journal of Psychoactive Drugs 2014 Amy Emerson, Linnae Ponté, Lisa Jerome et al. 64 citations

This article describes the teenage vision of the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) that humanity's future would be aided by the therapeutic and spiritual potential of psychedelic substances. The article traces the trajectory of MAPS from inception in 1986 to its present, noting future goals with respect to research, outreach, and harm reduction. MAPS...

Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.

Current Drug Abuse Reviews 2014 Rafael G. Dos Santos, José A. Crippa, J P Machado-De-Sousa et al. 10 citations

Pharmacological treatments are available for alcohol, nicotine, and opioid dependence, and several drugs for cannabis-related disorders are currently under investigation. On the other hand, psychostimulant abuse and dependence lacks pharmacological treatment. Mesolimbic dopaminergic neurons mediate the motivation to use drugs and drug-induced euphoria, and psychostimulants (cocaine,...

DOI: 10.2174/1874473708666150107122741 (opens in new tab) Full text (opens in new tab) Salvinorin a Psychostimulant addiction Addiction treatment Dopamine regulation

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.

Current Drug Abuse Reviews 2014 Michael Winkelman 128 citations

Substances known as psychedelics, hallucinogens and entheogens have been employed in ethnomedical traditions for thousands of years, but after promising uses in the 1950's and 1960's they were largely prohibited in medical treatment and human research starting in the 1970's as part of the fallout from the war on drugs. Nonetheless, there are a number of studies which suggest that these...

DOI: 10.2174/1874473708666150107120011 (opens in new tab) Full text (opens in new tab) Psychedelic addiction treatment Psychedelic therapeutic mechanisms Psychedelic drug safety

sLORETA intracortical lagged coherence during breath counting in meditation-naïve participants

Frontiers in Human Neuroscience December 27, 2013 Patricia Milz, Pascal L Faber, D. Lehmann et al.

We investigated brain functional connectivity comparing no-task resting to breath counting (a meditation exercise but given as task without referring to meditation). Functional connectivity computed as EEG coherence between head-surface data suffers from localization ambiguity, reference dependence, and overestimation due to volume conduction. Lagged coherence between intracortical model...

Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.

Neuropsychopharmacology December 2013 Shigeyuki Yamamoto, Hiroyuki Ohba, Shingo Nishiyama et al.

Subanesthetic doses of ketamine, an N-methyl-D-aspartic acid (NMDA) antagonist, have a rapid antidepressant effect which lasts for up to 2 weeks. However, the neurobiological mechanism regarding this effect remains unclear. In the present study, the effects of subanesthetic doses of ketamine on serotonergic systems in conscious monkey brain were investigated. Five young monkeys underwent four...

Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Neuropharmacology December 2013 Jenny L Wiley, Julie A. Marusich, Timothy W Lefever et al.

Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences. As compounds that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compounds have appeared on the drug market. Two tetramethylcyclopropyl ketone indoles, UR-144...

DOI: 10.1016/j.neuropharm.2013.07.022 (opens in new tab) Full text (opens in new tab) Abuse liability Delta-9-tetrahydrocannabinol Drug discrimination Synthetic cannabinoids +2

Studying the relationship between dreaming and sleep-dependent memory processes: methodological challenges.

Behavioral and Brain Sciences December 1, 2013 Michael Schredl

The hypothesis that dreaming is involved in off-line memory processing is difficult to test because major methodological issues have to be addressed, such as dream recall and the effect of remembered dreams on memory. It would be fruitful--in addition to studying the ancient art of memory (AAOM) in a scanner--to study the dreams of persons who use AAOM regularly.

Astrocyte domains and the three-dimensional and seamless expression of consciousness and explicit memories.

Medical Hypotheses December 1, 2013 James M Robertson

The expression of consciousness and the site of memory storage within the brain are unknown despite over a century of intense empirical scrutiny. Recent anatomical studies show that human protoplasmic astrocytes form innumerable uniform polyhedral tessellating domains that are arranged three-dimensionally. This complex geometric structure provides a matrix for seamless and three-dimensional...